To print this article, all you need is to be registered or login on Mondaq.com.
Illinois State Representative La Shawn K. Ford (D) appears to
have prefiled the Illinois Compassionate Use and Research of
Entheogens Act (“Illinois CURE Act”) on December 5, 2022.
The CURE Act currently stands to be introduced as House Bill 00001.
The publically available “Bill Summary” for the IL CURE
Act can be found here.
If passed, the Illinois CURE Act legalizes and regulates the
provision of psilocybin and psilocybin services in Illinois.
Further, the Bill Summary specifically provides that the Illinois
Department of Public Health (“IDPH”) “shall begin
receiving applications for the licensing of persons to manufacture
or test psilocybin products, operate service centers, or facilitate
psilocybin services.”
According to the Bill Summary, the Illinois CURE Act also does
the following:
- Establishes the Illinois Psilocybin Advisory Board to advise
and make recommendations to the IDPH regarding the provision of
psilocybin and psilocybin services; - Expunges specified records concerning the possession of
psilocybin and psilocin; - Removes psilocybin and psilocin from the list of Schedule I
controlled substances; - Provides provisions concerning rulemaking, taxes, fees, zoning,
labeling, and penalties; - Preempts home rule powers;
- Creates the Psilocybin Control and Regulation Fund and the
Illinois Psilocybin Fund and makes conforming changes in the State
Finance Act; - Requires the Department of Agriculture, the Illinois Liquor
Control Commission, and the Department of Revenue to perform
specified duties; and - Amends aspect of Illinois tax related to the legislation.
The Illinois General Assembly convenes its regular session on
January 11, 2023. Further updates will be provided regarding the
full text of the legislation when available.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States